Opportunity
DIBBS #SPE2DP-26-T-2785
DLA Solicitation for Gabapentin Capsules, 100 mg, 100-count Bottles
Posted
April 10, 2026
Respond By
April 15, 2026
Identifier
SPE2DP-26-T-2785
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA is seeking quotations for Gabapentin Capsules to support military medical needs. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - OEMs (Approved Manufacturers): - Marlex Pharmaceuticals Inc (NDC10135-0644-01) - Cipla USA Inc (NDC69097-0813-07) - Sciegen Pharmaceuticals Inc (NDC50228-0179-01) - Products Requested: - Gabapentin Capsules, 100 mg, 100-count bottles - National Stock Number (NSN): 6505-01-387-1892 - Quantity: 5 bottles - Shelf life: 36 months, non-extendable - Packaging and marking must comply with DLA medical standards and FDA regulations - Delivery Requirements: - Delivery required within 5 days FOB destination to USS Makin Island LHD 8, FPO AP 96672 - Notable Requirements: - Compliance with Buy American Act - NIST SP 800-171 cybersecurity assessments - Hazardous material labeling requirements
Description
GABAPENTIN CAPSULES (QTY: 5, NSN: 6505-01-387-1892, Purchase Request: 7016153280) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC